Table: Taiko Pharmaceutical -2015/16 group results

Taiko Pharmaceutical

13/05/2016 07:05

May 13 (Reuters)-  
          Taiko Pharmaceutical Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to       NEXT    
                Mar 31, 2016    Mar 31, 2015   Mar 31, 2017     YEAR      
                   LATEST         YEAR-AGO        COMPANY      COMPANY    
                   RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales             8.33            8.98           8.40                   
                 (-7.3 pct)      (-9.7 pct)     (+0.9 pct)                
  Operating         1.35            2.56           1.35                   
                 (-47.3 pct)     (-1.2 pct)     (+0.2 pct)                
  Recurring         1.31            2.78           1.11                   
                 (-52.9 pct)     (+3.5 pct)     (-15.1 pct)               
  Net 
  Net              840 mln          1.77          850 mln                 
                 (-52.6 pct)     (+1.3 pct)     (+1.2 pct)                
  EPS             65.23 yen      138.93 yen      65.24 yen                
  EPS Diluted     63.83 yen      134.47 yen                               
  Ann Div         15.00 yen       25.00 yen      15.00 yen                
  -Q2 Div            NIL             NIL            NIL                   
  -Q4 Div         15.00 yen       25.00 yen      15.00 yen                
   
  NOTE - Taiko Pharmaceutical Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T 
  ((Tokyo Headline News Desk +813 6441 1812))